The Evolving Landscape of Psychedelic Policy
We sat down with Ismail L. Ali, Allison Hoots, and Joshua Kappel to explore the rapidly evolving landscape of psychedelic policy. The conversation examined how federal and state reforms are taking shape, what real-world psychedelic use means for regulation, and how policymakers, advocates, and communities can work toward more equitable models of access.
Inside This Conversation
The Current Policy Landscape
Our panel unpacked the latest federal and state developments, including emerging regulatory pathways, legislative momentum, and the broader forces shaping psychedelic reform.
Real-World Access and Microdosing
We explored how millions of people are already engaging with psychedelics outside of clinical settings, and what that means for designing policies that reflect real-world use.
Equity, Repair, and Lessons from Cannabis
The discussion examined what meaningful access and repair could look like as psychedelic policy evolves, along with key lessons from cannabis legalization - both what worked and what should be done differently.
What Drives Change
From scientific research and clinical outcomes to storytelling, advocacy, and cultural momentum, we explored the factors that are influencing the future of psychedelic policy.
.svg)
Speakers & Hosts
Ismail L Ali, J.D.
Co-Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS)
Allison Hoots, Esq.
Founder and Principal Attorney of Hoots Law Practice PLLC, Head Policy Counsel at New Yorkers for Mental Health Alternatives
Joshua Kappel
Psychedelic Lawyer, Co-Founder of Microdosing Collective, Founding Partner of Vicente LLP
Alli Schaper
Co-Founder of Microdosing Collective, Co-Founder of SuperMush, and Host of Into the Multiverse Podcast.
Chelsea Coyle
Executive Director & Creative Director of Microdosing Collective
